Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Assets (Quarterly): 883.76M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 883.76M |
| March 31, 2024 | 955.15M |
| December 31, 2023 | 626.29M |
| September 30, 2023 | 765.55M |
| June 30, 2023 | 795.86M |
| March 31, 2023 | 891.31M |
| December 31, 2022 | 891.49M |
| September 30, 2022 | 691.94M |
| June 30, 2022 | 751.78M |
| March 31, 2022 | 703.58M |
| December 31, 2021 | 638.54M |
| September 30, 2021 | 710.15M |
| June 30, 2021 | 734.93M |
| March 31, 2021 | 756.80M |
| December 31, 2020 | 499.25M |
| September 30, 2020 | 522.50M |
| June 30, 2020 | 555.73M |
| March 31, 2020 | 561.08M |
| December 31, 2019 | 587.60M |
| September 30, 2019 | 349.85M |
| June 30, 2019 | 336.83M |
| March 31, 2019 | 333.94M |
| December 31, 2018 | 340.95M |
| September 30, 2018 | 111.61M |
| June 30, 2018 | 112.90M |
| Date | Value |
|---|---|
| March 31, 2018 | 127.00M |
| December 31, 2017 | 88.22M |
| September 30, 2017 | 104.02M |
| June 30, 2017 | 115.08M |
| March 31, 2017 | 126.87M |
| December 31, 2016 | 144.26M |
| September 30, 2016 | 128.18M |
| June 30, 2016 | 85.53M |
| March 31, 2016 | 94.61M |
| December 31, 2015 | 111.38M |
| September 30, 2015 | 132.27M |
| June 30, 2015 | 145.19M |
| March 31, 2015 | 162.38M |
| December 31, 2014 | 162.14M |
| September 30, 2014 | 182.82M |
| June 30, 2014 | 196.62M |
| March 31, 2014 | 202.64M |
| December 31, 2013 | 92.69M |
| September 30, 2013 | 37.33M |
| June 30, 2013 | 41.49M |
| March 31, 2013 | 12.42M |
| December 31, 2012 | 15.23M |
| September 30, 2012 | 16.53M |
| June 30, 2012 | 16.49M |
| March 31, 2012 | 20.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
499.25M
Minimum
Dec 2020
955.15M
Maximum
Mar 2024
711.75M
Average
710.15M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Vaxcyte Inc | 3.560B |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 544.78M |
| Shareholders Equity (Quarterly) | 330.55M |